Question 1

Has Ronald Levy received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $792,605 in general payments to Ronald Levy across 60 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Ronald Levy did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Ronald Levy come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Amgen	2	$351,721
Janssen Research & Development, LLC	27	$223,866
Beigene, Ltd.	17	$85,000
E.r. Squibb & Sons, L.L.C.	2	$67,724
Pfizer	2	$29,206
OPKO Pharmaceuticals, LLC	2	$20,000
Beone Medicines USA, Inc.	3	$11,667
Beone Medicines Ltd.	1	$3,333
Ferring Pharmaceuticals Inc.	4	$88

Ronald Levy

Payments from drug & device makers

Who reported the general payments

How this compares

Other medical oncology in Stanford